Diving Deeper: Neuralink’s Reassurance Amid Monkey Deaths Raises Eyebrows
Noland Arbaugh, Neuralink’s first patient, initially harbored doubts about the company’s practices before undergoing surgery, specifically regarding the treatment of monkeys used for testing. However, after conversing with Neuralink staff, Arbaugh’s apprehensions were alleviated. Despite past grim reports, including instances of brain damage in test monkeys, Arbaugh now expresses confidence in Neuralink’s procedures. His blunt dismissal of skeptics reflects his newfound trust in the company post-discussion with the team.